Pinz Capital Management, LP Syndax Pharmaceuticals Inc Transaction History

Pinz Capital Management, LP

  • $55.2 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$15.23 - $22.47 $150,777 - $222,453
-9,900 Closed
0 $0
Q3 2021

Nov 15, 2021
BUY
$13.87 - $19.8 $137,313 - $196,020
9,900 New
9,900 $189,000
Q1 2021

May 17, 2021
SELL
$19.28 - $24.59 $2.44 Million - $3.11 Million
-126,352 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
$15.1 - $26.44 $1.91 Million - $3.34 Million
126,352 New
126,352 $2.81 Million

Others Institutions Holding SNDX

# of Institutions
227
Shares Held
88.3M
Call Options Held
1.01M
Put Options Held
692K
View Full List

About Syndax Pharmaceuticals Inc

SNDX Quotes by TradingView
  • Ticker SNDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 56,565,200
  • Market Cap $910M
  • Description
  • Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...
More about SNDX
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email